- Home
- Health & Fitness
- Diseases
- 2024-25 Guide to Medications for the Treatment of Diabetes Mellitus
2024-25 Guide to Medications for the Treatment of Diabetes Mellitus
List Price:
$69.95
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
John R. White, Joshua J. Nuemiller
Format:
Paperback
Pages:
644
Publisher:
American Diabetes Association (July 9, 2024)
Language:
English
ISBN-13:
9781580408387
ISBN-10:
1580408389
Dimensions:
6" x 9" x 1.38"
File:
PGW-LEGATO-Metadata_Only_Publishers_Group_West_Customer_Group_Metadata_20250917130149-20250918.xml
Folder:
PGW
List Price:
$69.95
Country of Origin:
United States
Pub Discount:
65
Case Pack:
26
As low as:
$53.86
Publisher Identifier:
P-PER
Discount Code:
A
Weight:
28oz
Imprint:
American Diabetes Association
Overview
The 2024-25 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide addresses all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Each discussion reflects the latest guidance of the American Diabetes Association’s Standards of Care in Diabetes. This guide also features chapters on medication management of comorbidities such as:
• Neuropathy
• Chronic Kidney Disease
• Retinopathy
• Hypoglycemia
• Obesity
• Depression
• Neuropathy
• Chronic Kidney Disease
• Retinopathy
• Hypoglycemia
• Obesity
• Depression
